Flavoured water consumption alters pharmacokinetic parameters and increases exposure of erlotinib and gefitinib in a preclinical study using Wistar rats

被引:0
作者
Almomen, Aliyah [1 ]
Maher, Hadir M. [2 ]
Alzoman, Nourah Z. [1 ]
Shehata, Shereen M. [1 ]
Alsubaie, Amal [3 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia
[2] Alexandria Univ, Fac Pharm, Dept Pharmaceut Analyt Chem, Alexandria, Egypt
[3] Saudi Food & Drug Author, Biol Prod Evaluat Directorate, Riyadh, Saudi Arabia
关键词
Flavored water; Tyrosin Kinase Inhibitors; Erlotinib; Gefitinib; Pharmacokinetic; Rat; Drug interaction; Toxicity; In vivo; UPLC; TYROSINE KINASE INHIBITORS; P-GLYCOPROTEIN INHIBITORS; PRIMARY HUMAN HEPATOCYTES; GRAPEFRUIT JUICE; CRANBERRY JUICE; CLINICAL PHARMACOKINETICS; FRUIT JUICES; LUNG-CANCER; IN-VITRO; DRUG;
D O I
10.7717/pearj.9881
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. Erlotinib (ERL) and gefitinib (GEF) are considered first line therapy for the management of non-small cell lung carcinoma (NSCLC). Like other tyrosine kinase inhibitors (TKIs), ERL and GEF are mainly metabolized by the cytochrome P450 (CYP450) CYP3A4 isoform and are substrates for transporter proteins with marked inter-/intra-individual pharmacokinetic (PK) variability. Therefore, ERL and GEF are candidates for drug-drug and food-drug interactions with a consequent effect on drug exposure and/or drug-related toxicities. In recent years, the consumption of flavoured water (FW) has gained in popularity. Among multiple ingredients, fruit extracts, which might constitute bioactive flavonoids, can possess an inhibitory effect on the CYP450 enzymes or transporter proteins. Therefore, in this study we investigated the effects of different types of FW on the PK parameters of ERL and GEF in Wistar rats. Methods. ERL and GEF PK parameters in different groups of rats after four weeks consumption of different flavours of FW, namely berry, peach, lime, and pineapple, were determined from plasma drug concentrations using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Results. Data indicated that tested FWs altered the PK parameters of both ERL and GEF differently. Lime water had the highest impact on most of ERL and GEF PK parameters, with a significant increase in C-max. (95% for ERL, 58% for GEF), AUC(0-48) (111% for ERL, 203% for GEF), and AUC(0-infinity), (200% for ERL, 203% for GEF), along with a significant decrease in the apparent oral clearance of both drugs (65% for ERL, 67% for GEF). The order by which FW affected the PK parameters for ERL and GEF was as follows: lime > pineapple > berry > peach. Conclusion. The present study indicates that drinking FW could be of significance in rats receiving ERL or GEF. Our results indicate that the alteration in PKs was mostly recorded with lime, resulting in an enhanced bioavailability, and reduced apparent oral clearance of the drugs. Peach FW had a minimum effect on the PK parameters of ERL and no significant effect on GEF PKs. Accordingly, it might be of clinical importance to evaluate the PK parameters of ERL and GEF in human subjects who consume FW while receiving therapy.
引用
收藏
页数:18
相关论文
共 64 条
[51]  
Purdy C., 2019, AM WANT DRINK MORE W
[52]   Effect of health foods on cytochrome P450-mediated drug metabolism [J].
Takamitsu Sasaki ;
Yu Sato ;
Takeshi Kumagai ;
Kouichi Yoshinari ;
Kiyoshi Nagata .
Journal of Pharmaceutical Health Care and Sciences, 3 (1)
[53]   Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors Focus on 4-Anilinoquinazolines [J].
Scheffler, Matthias ;
Di Gion, Paola ;
Doroshyenko, Oxana ;
Wolf, Juergen ;
Fuhr, Uwe .
CLINICAL PHARMACOKINETICS, 2011, 50 (06) :371-403
[54]   DO CALORIES, OSMOLALITY, OR CALCIUM DETERMINE GASTRIC-EMPTYING [J].
SHAFER, RB ;
LEVINE, AS ;
MARLETTE, JM ;
MORLEY, JE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (04) :R479-R483
[55]   Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats [J].
Shin, SC ;
Choi, JS ;
Li, XG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 313 (1-2) :144-149
[56]   Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100 [J].
Smith, N. F. ;
Baker, S. D. ;
Gonzalez, F. J. ;
Harris, J. W. ;
Figg, W. D. ;
Sparreboom, A. .
BRITISH JOURNAL OF CANCER, 2008, 98 (10) :1630-1632
[57]   Food Polyphenol Apigenin Inhibits the Cytochrome P450 Monoxygenase Branch of the Arachidonic Acid Cascade [J].
Steuck, Maryvonne ;
Hellhake, Stefan ;
Schebb, Nils Helge .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2016, 64 (47) :8973-8976
[58]   Next-Generation EGFR Tyrosine Kinase Inhibitors for Treating EGFR-Mutant Lung Cancer beyond First Line [J].
Sullivan, Ivana ;
Planchard, David .
FRONTIERS IN MEDICINE, 2017, 3
[59]   Lung Cancer Statistics [J].
Torre, Lindsey A. ;
Siegel, Rebecca L. ;
Jemal, Ahmedin .
LUNG CANCER AND PERSONALIZED MEDICINE: CURRENT KNOWLEDGE AND THERAPIES, 2016, 893 :1-19
[60]   Effects of cranberry juice on nifedipine pharmacokinetics in rats [J].
Uesawa, Yoshihiro ;
Mohri, Kiminori .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (08) :1067-1072